News

Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg/mL autoinjector ...
There are multiple chapters near you. Select your preferred chapter.
New research by Swansea University and the University of Cambridge has revealed the causes and devastating impacts of delays – that can last decades - in diagnosing lupus, an auto-immune condition.
People with leukemia are prone to a range of skin-related problems, from rashes and bruising to infections and bleeding into the skin. How to spot the telltale signs.
New research by Swansea University and Cambridge University has revealed the causes and devastating impacts of delays—that ...
Circular rashes may be puzzling—and alarming. The instant most individuals catch sight of a circle or ring-shaped area on the ...
She said: “Lupus was seen as something that was life-limiting. That’s changed and over the last few years – there’s really ...
Researchers from EMD Serono and global collaborators shared promising results from Cohort B of the phase II trial of the WILLOW study.
Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...
Lupus causes a higher risk of kidney disease and other complications in Black women. Learn why early diagnosis and awareness are vital.